Up next

Autoplay

Treating Polycythemia Vera Patients Refractory to Hydroxyurea

0 Views • 08/19/25
Share
Side Effects
Side Effects
Subscribers
0

In a case study of a 45-year old man with polycythemia vera is refractory to hydroxyurea, Srdan Verstovsek, MD, PhD of the MD Anderson Cancer Center in Houston, Texas describes how ruxolitinib is a viable treatment option.

Show more
0 Comments sort Sort By

Up next

Autoplay